Search Results - "Lin, Xiangliang"

Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors by Rhazi, Halima, Safini, Najete, Mikou, Karima, Alhyane, Meryeme, Tadlaoui, Khalid Omari, Lin, Xiangliang, Venkatesan, Nandini P, Elharrak, Mehdi

“…Animal vaccination is an important way to stop the spread of diseases causing immense damage to livestock and economic losses and the potential transmission to…”
Get full text

SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor by Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Pihl, Anne Finne, Costa, Rui, Venkatesan, Nandini Prabhakar, Lin, Xiangliang, Van Pham, Long, Feng, Shan, Fahnøe, Ulrik, Scheel, Troels Kasper Høyer, Ramirez, Santseharay, Reichl, Udo, Bukh, Jens, Genzel, Yvonne, Gottwein, Judith Margarete

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based…”
Get full text

High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor by Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Pihl, Anne Finne, Venkatesan, Nandini Prabhakar, Krarup, Henrik, Lin, Xiangliang, Reichl, Udo, Bukh, Jens, Genzel, Yvonne, Gottwein, Judith Margarete

“…Hepatitis C virus (HCV) infections pose a major public health burden due to high chronicity rates and associated morbidity and mortality. A vaccine protecting…”
Get full text

Secretomes as an emerging class of bioactive ingredients for enhanced cosmeceutical applications by Tan, Kei‐Xian, Chang, Trixie, Lin, Xiangliang

“…Skin ageing is predominantly caused by either intrinsic or extrinsic factors, leading to undesirable skin features. Advancements in both molecular and cellular…”
Get full text

Optimization of culture conditions for human bone marrow‐derived mesenchymal stromal cell expansion in macrocarrier‐based Tide Motion system by Bhat, Samatha, Chiew, Geraldine Giap Ying, Ng, Jia Xing, Lin, Xiangliang, Seetharam, Raviraja N.

“…Background With high cell doses required for mesenchymal stromal cell (MSC) clinical trials, there is a need to upgrade technologies that facilitate efficient…”
Get full text